FACTORS INFLUENCING THE DURATION OF COUGH AFTER ACUTE RESPIRATORY TRACT INFECTIONS
Keywords:
Keywords: acute respiratory tract infection; postinfectious cough; cough duration; airway inflammation; bronchial hyperresponsiveness; cough hypersensitivity; mucociliary clearance; risk factorsAbstract
Cough is one of the most persistent symptoms after an acute respiratory tract infection (ARTI), and its duration may extend beyond the period of fever, rhinorrhea, and other acute manifestations. A cough lasting three to eight weeks after an otherwise resolving respiratory infection is commonly described as postinfectious cough. Although it is usually self-limited, its persistence is influenced by interacting biological, clinical, behavioral, and environmental factors. This article reviews the main determinants of prolonged postinfectious cough, with particular attention to airway inflammation, transient bronchial hyperresponsiveness, impaired mucociliary clearance, mucus production, cough-reflex hypersensitivity, the type and severity of the initial infection, previous episodes of prolonged cough, smoking and other airway irritants, asthma and upper-airway disease, gastroesophageal reflux, and selected infectious causes such as Bordetella pertussis. Evidence indicates that the intensity of acute symptoms alone is an imperfect predictor of cough persistence, whereas previous postinfectious cough and increased cough sensitivity may identify individuals at greater risk. Recognition of these factors is important for appropriate reassurance, avoidance of unnecessary antibiotics, and identification of patients who require evaluation for asthma, sinus disease, reflux, pertussis, pneumonia, or another cause of chronic cough.
References
1.Ebell MH, Radke T. How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature. Ann Fam Med. 2013;11(1):5–13.
2.Braman SS. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):138S–146S.
3.Irwin RS, French CL, Chang AB, Altman KW. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153(1):196–209.
4.Lin L, et al. The duration of cough in patients with H1N1 influenza. Clinical Respiratory Journal. 2017;11(6):733–738.
5.Hegele RG, Hayashi S, Hogg JC, Pare PD. Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections. American Journal of Respiratory and Critical Care Medicine. 1995;151(5):1659–1664.
6.El-Gohary M, Hay AD, Coventry P, et al. Corticosteroids for acute and subacute cough following respiratory tract infection: a systematic review. Family Practice. 2013;30(5):492–500.
7.Schroeder K, Fahey T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ. 2002;324:329–331.
8.Zhang J, et al. Risk factors for chronic cough in adults: a systematic review and meta-analysis. Respirology. 2022;27(1):6–20.